Medical Weight‐Loss Outcomes in Patients Receiving Concomitant Psychotropic Medication: A Retrospective Cohort Study

Obesity ◽  
2020 ◽  
Vol 28 (9) ◽  
pp. 1671-1677
Author(s):  
Alpana P. Shukla ◽  
Lindsay S. Mandel ◽  
Beverly G. Tchang ◽  
Ethan Litman ◽  
Joshua Cadwell ◽  
...  
2017 ◽  
Author(s):  
Christine Hill ◽  
Brian W Weir ◽  
Laura W Fuentes ◽  
Alicia Garcia-Alvarez ◽  
Danya P Anouti ◽  
...  

2018 ◽  
Vol 6 (4) ◽  
pp. e83 ◽  
Author(s):  
Christine Hill ◽  
Brian W Weir ◽  
Laura W Fuentes ◽  
Alicia Garcia-Alvarez ◽  
Danya P Anouti ◽  
...  

2020 ◽  
Vol 9 (11) ◽  
pp. 3596
Author(s):  
Giorgio Bedogni ◽  
Graziano Grugni ◽  
Sabrina Cicolini ◽  
Diana Caroli ◽  
Sofia Tamini ◽  
...  

Few short-term studies of weight loss have been performed in adult patients with Prader–Willi syndrome (PWS) undergoing metabolic rehabilitation. We performed a retrospective cohort study of 45 adult obese PWS patients undergoing a long-term multidisciplinary metabolic rehabilitation program based on diet and physical activity. Body composition was evaluated by dual-energy X-ray absorptiometry in 36 (80%) patients. The mean (95% CI) weight change was −3.6 (−7.6 to 0.4, p = 0.08) kg at 3 years and −4.6 (−8.5 to −0.8, p = 0.02) kg at 6 years, and that of BMI was −1.7 (−3.4 to 0.1, p = 0.06) kg/m2 at 3 years and −2.1 (−3.8 to −0.4, p = 0.02) kg/m2 at 6 years. A decrease of about 2% in fat mass per unit of body mass was observed, which is in line with the expectations for moderate weight loss. A possibly clinically relevant decrease in total and low-density lipoprotein cholesterol was also observed. These long-term results are important for patients with PWS, which is characterized by severe hyperphagia, behavioral disturbances, and cognitive impairment and is generally considered “resistant” to classical weight loss interventions.


2021 ◽  
Vol 46 ◽  
pp. S607-S608
Author(s):  
A.M. Loff ◽  
A.L. Jakobsen ◽  
T. Munk ◽  
A.W. Knudsen

Sign in / Sign up

Export Citation Format

Share Document